148 related articles for article (PubMed ID: 6583197)
1. Susceptibility of anaerobic bacteria to imipenem.
Tally FP; Jacobus NV
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():47-51. PubMed ID: 6583197
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of imipenem against anaerobic bacteria.
Wexler HM; Finegold SM
Rev Infect Dis; 1985; 7 Suppl 3():S417-25. PubMed ID: 3901206
[TBL] [Abstract][Full Text] [Related]
3. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
[TBL] [Abstract][Full Text] [Related]
5. Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group.
Eley A; Greenwood D
J Antimicrob Chemother; 1984 Mar; 13(3):245-55. PubMed ID: 6725175
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.
Jacobus NV; Tally FP; Gorbach SL
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():189-91. PubMed ID: 4030547
[TBL] [Abstract][Full Text] [Related]
7. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT
Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of imipenem against gram-positive anaerobic bacteria.
Dubreuil L; Devos J; Romond C
Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1986 Jan; 29(1):158-60. PubMed ID: 3460519
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers.
Sheikh W; Pitkin DH; Nadler H
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S361-6. PubMed ID: 8324148
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of Sch 34343 against anaerobic bacteria.
Wexler H; Carter WT; Finegold SM
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():173-6. PubMed ID: 3861606
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Brown JE; Del Bene VE; Collins CD
Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
Byun JH; Kim M; Lee Y; Lee K; Chong Y
Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of L-627 against anaerobic bacteria.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
[TBL] [Abstract][Full Text] [Related]
16. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Rezvan SP; Sidorenko SV; Budanov SV
Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
[TBL] [Abstract][Full Text] [Related]
17. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Eley A; Greenwood D
J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics.
Heseltine PN; Appleman MD; Leedom JM
Rev Infect Dis; 1984; 6 Suppl 1():S254-9. PubMed ID: 6585882
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of anaerobic bacteria to meropenem.
Nord CE; Lindmark A; Persson I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of anaerobic bacteria to antimicrobial agents.
Collignon PJ; Munro R; Morris G
Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
